Literature DB >> 21435909

Medically intractable temporal lobe epilepsy in patients with normal MRI: surgical outcome in twenty-one consecutive patients.

Adam P Smith1, Sepehr Sani, Andres M Kanner, Travis Stoub, Matthew Morrin, Susan Palac, Donna C Bergen, Antoaneta Balabonov, Michael Smith, Walter W Whisler, Richard W Byrne.   

Abstract

INTRODUCTION: Abnormal MRI findings localizing to the mesial temporal lobe predict a favorable outcome in temporal lobe epilepsy surgery. The purpose of this study is to summarize the surgical outcome of patients who underwent a tailored antero-temporal lobectomy (ATL) with normal 1.5 T MRI. Specifically, factors that may be associated with favorable post-surgical seizure outcome are evaluated.
METHODS: A retrospective analysis of the Rush University Medical Center surgical epilepsy database between 1992 and 2003 was performed. Patients who underwent an ATL and had a normal MRI study documented with normal volumetric measurements of hippocampal formations and the absence of any other MRI abnormality were selected for this study. Demographic information was collected on all patients. Seizure outcomes were evaluated using Engel's classification. A two-sided Fisher exact test with Bonferroni correction was performed in statistical analyses.
RESULTS: Twenty-one (21) patients met the inclusion criteria of normal 1.5 T MRI and underwent a tailored temporal lobectomy. Mean age at time of surgery was 28 years (SD=8.1, range 11-44) and mean duration of the seizure disorder was 13.4 years (range 2-36). Risk factors for epilepsy included head injury (n=4), encephalitis (n=3), febrile seizures (n=2), and 12 patients had no risk factors. Pathological evaluation of resected tissue revealed no abnormal pathology in 12/21 patients (57%). After a mean 4.8 years follow-up post-surgical period, 15/21 (71%) patients were free of disabling seizures (Engel I outcome). At 8.3 years follow-up, 13/21 (62%) patients had similar results. Absence of prior epilepsy risk factors was the only statistically significant predictor of an Engel class I outcome (p<0.0022).
CONCLUSION: Patients with medically intractable epilepsy and normal MRI appear to benefit from epilepsy surgery. Absence of prior epilepsy risk factors may be a positive prognostic factor.
Copyright © 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21435909     DOI: 10.1016/j.seizure.2011.02.013

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  6 in total

1.  Which Hippocampal Sclerosis is Imaged With 7-T MRI?

Authors:  Gregory L Krauss
Journal:  Epilepsy Curr       Date:  2012-05       Impact factor: 7.500

2.  Preoperative prediction of temporal lobe epilepsy surgery outcome.

Authors:  Daniel M Goldenholz; Alexander Jow; Omar I Khan; Anto Bagić; Susumu Sato; Sungyoung Auh; Conrad Kufta; Sara Inati; William H Theodore
Journal:  Epilepsy Res       Date:  2016-09-22       Impact factor: 3.045

3.  Imaging in medically refractory epilepsy at 3 Tesla: a 13-year tertiary adult epilepsy center experience.

Authors:  Nicolin Hainc; Mary Pat McAndrews; Taufik Valiante; Danielle M Andrade; Richard Wennberg; Timo Krings
Journal:  Insights Imaging       Date:  2022-06-04

4.  Impaired and facilitated functional networks in temporal lobe epilepsy.

Authors:  Luigi Maccotta; Biyu J He; Abraham Z Snyder; Lawrence N Eisenman; Tammie L Benzinger; Beau M Ances; Maurizio Corbetta; R Edward Hogan
Journal:  Neuroimage Clin       Date:  2013-06-25       Impact factor: 4.881

Review 5.  Temporal lobe resective surgery for medically intractable epilepsy: a review of complications and side effects.

Authors:  Iordanis Georgiadis; Effie Z Kapsalaki; Kostas N Fountas
Journal:  Epilepsy Res Treat       Date:  2013-10-31

6.  Seizure outcomes of temporal lobe epilepsy surgery in patients with normal MRI and without specific histopathology.

Authors:  Jugoslav Ivanovic; Pål G Larsson; Ylva Østby; John Hald; Bård K Krossnes; Jan G Fjeld; Are H Pripp; Kristin Å Alfstad; Arild Egge; Milo Stanisic
Journal:  Acta Neurochir (Wien)       Date:  2017-03-09       Impact factor: 2.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.